Ning Zhi

Title: Ning Zhi: Innovator in Viral Research

Introduction

Ning Zhi is a prominent inventor based in Rockville, MD (US). She has made significant contributions to the field of viral research, particularly in the study of human parvovirus B19. With a total of 2 patents, her work has implications for the treatment and prevention of viral infections.

Latest Patents

Ning Zhi's latest patents focus on the development of infectious clones of human parvovirus B19. These inventions relate to methods of cloning infectious B19 clones and viral genomes that possess secondary DNA structures unstable in bacterial cells. The B19 infectious clone and the methods for producing these clones are crucial for generating infectious virus. This infectious virus is instrumental in identifying and developing therapeutically effective compositions for the treatment and prevention of human parvovirus B19 infections.

Career Highlights

Throughout her career, Ning Zhi has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the Institut National De La Recherche Scientifique. Her work in these institutions has furthered the understanding of viral infections and their potential treatments.

Collaborations

Ning Zhi has collaborated with esteemed colleagues such as Kevin Edward Brown and Peter Tijssen. These partnerships have enhanced her research and contributed to the advancement of knowledge in her field.

Conclusion

Ning Zhi's innovative work in the field of viral research, particularly regarding human parvovirus B19, showcases her dedication to advancing medical science. Her patents and collaborations reflect her significant impact on the development of therapeutic solutions for viral infections.